The Scotts Miracle-Gro CompanySMGNYSE
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average, modest growth trend.
Left:
||||
Year-over-year research & development expense growth
Latest
-100.00%
↓ 1442% below average
Average (39q)
7.45%
Historical baseline
Range
High:408.70%
Low:-100.00%
CAGR
+4.9%
Modest growth trend
| Period | Value |
|---|---|
| Q4 2025 | -100.00% |
| Q3 2025 | 1.11% |
| Q2 2025 | -1.10% |
| Q1 2025 | 19.74% |
| Q4 2024 | -19.15% |
| Q3 2024 | 9.30% |
| Q2 2024 | 4.88% |
| Q1 2024 | -2.38% |
| Q4 2023 | -11.58% |
| Q3 2023 | 5.56% |
| Q3 2023 | 8.43% |
| Q2 2023 | -6.74% |
| Q4 2022 | -11.00% |
| Q3 2022 | -3.85% |
| Q3 2022 | -16.13% |
| Q2 2022 | -0.80% |
| Q1 2022 | -6.72% |
| Q3 2021 | 17.54% |
| Q3 2021 | 10.68% |
| Q2 2021 | 0.00% |
| Q1 2021 | -11.97% |
| Q3 2020 | 28.57% |
| Q2 2020 | -6.19% |
| Q1 2020 | 5.43% |
| Q4 2019 | -14.81% |
| Q3 2019 | 5.88% |
| Q2 2019 | 8.51% |
| Q1 2019 | 2.17% |
| Q4 2018 | -22.03% |
| Q3 2018 | 8.26% |
| Q2 2018 | 3.81% |
| Q1 2018 | 11.70% |
| Q4 2017 | 100.00% |
| Q3 2017 | -62.70% |
| Q3 2017 | 7.69% |
| Q2 2017 | 408.70% |
| Q4 2016 | -81.15% |
| Q3 2016 | -2.40% |
| Q3 2016 | 26.26% |
| Q2 2016 | -15.38% |